MediNect Ophtho

We are a collaborative preclinical CRO, with a primary focus on in vivo studies of retinal diseases.

[MediNect Ophtho @MediNectBio]

Come visit poster 0138 in the poster hall where Dr Kevin Harkin, our Head of Ophthalmology, will be presenting data on

‘Unmasking EMT: A fibrotic Package Linking scRNA-seq insights to ARPE-19 functional assays’

#ARVO2026 #denver #fibrosis #AMD

[MediNect Ophtho @MediNectBio]

In 2024 we received a grant from DTFF to get equipment to establish a new 3D model without animals.
#AnimalStats #3Rs #OpennessInAnimalResearch

[MediNect Ophtho @MediNectBio]

🧫 We’re developing a new 3D model to better replicate human biology without using animals.
🔬 This system supports drug discovery while advancing the 3Rs—especially Replacement.
🌱 Proud to push for more ethical, human-relevant science
#AnimalStats #3Rs #OpennessInAnimalResearch

[MediNect Ophtho @MediNectBio]

🧬 At MediNect we work with biopharma to develop new drugs for people suffering from blindness
🐁 Animal models have been vital in advancing drug development
🔄 We continue to apply the 3Rs—Refine, Reduce, Replace—to minimise animal use
#AnimalStats #3Rs #OpennessInAnimalResearch

[MediNect Ophtho @MediNectBio]

Want to learn more about the subretinal fibrosis model and THE model for anti-VEGF non-responders?

Comment on here to book a follow-up meeting at #ARVO2024!!

#RETINA #Collaboration #preclinicalCRO #nAMD #subretinalfibrosis

https://t.co/qjYxMDMAtT

@Alanretina @MedinaReinhold

[MediNect Ophtho @MediNectBio]

🔬Fantastic #ARVO2024 Day 1!

Such interest & great feedback on our subretinal fibrosis model presented by Dr Kevin Harkin, developed by the esteemed researchers @QUBelfast

Reach out to us to book a follow-up meeting here @ ARVO!

#AMD #partnering #new #preclinicalCRO

[MediNect Ophtho @MediNectBio]

🔬Excited for #ARVO2024 Day 1!

Join us at Poster B0220 where Dr. Kevin Harkin will present our validation of the subretinal fibrosis model, an exciting model for fibrosis in nAMD. Visit from 13:00-14:45 to learn more. See you there! #VisionResearch #Preclinical #Collaboration

[MediNect Ophtho @MediNectBio]

The countdown is on! One week from today, the MediNect team will be at #ARVO2024! Get in touch to meet us there to chat all things preclinical: https://t.co/5j4jhPdKPv

#ARVO #OphthalmologyResearch #PreclinicalCRO

[MediNect Ophtho @MediNectBio]

Huge congratulations @EyeDaisyShu

See you at #ARVO2024

[Retinal Research Group (Shu Lab) @retinalresgroup]

So thrilled to be awarded the @ASIPath Young Investigator Leadership Award and the Dani and Erik Zander Junior Faculty Scholar Award! #asip2024 🥳🥂 @EyeDaisyShu @UNSWoptomvsci #ScientiaFellows

[MediNect Ophtho @MediNectBio]

@DublinAirport @JetBlue Liked and commented - fingers crossed - would be great seeing our Boston friends

[MediNect Ophtho @MediNectBio]

We’ve just registered for #ATE23! Who’s coming? @Phacilitate. https://t.co/OLXBfOhrgG

[MediNect Ophtho @MediNectBio]

Our CEO James is at #Climb23 today at #LeedsDock.

Connect on LinkedIn or in here to meet up!!

#preclinical #scaleup #networking

[MediNect Ophtho @MediNectBio]

Cancelled @Delta flight from Dublin yesterday. New flight booked to #NewOrleans with @AerLingus. Connecting flight in NYC cancelled with a 10 (ten) hour delay before cancellation. Running on empty and no sleep but we’re FINALLY on a flight to #NewOrleans. See you soon #ARVO2023

[MediNect Ophtho @MediNectBio]

Less than a week to #ARVO2023. Come visit us at Booth #1248 to learn more about us (and check out some more cool images like this OIR Tuft)

#RetinalDisease #preclinicalCRO #Belfast

[MediNect Ophtho @MediNectBio]

New #newsletter on @LinkedIn about preclinical in vivo models of #retinaldisease. Our first edition includes advantages/disadvantages of mouse models for #diabeticretinopathy. We offer these models & expert advice. Check it out!

https://t.co/A44X9dCPiX

[MediNect Ophtho @MediNectBio]

Excited to attend the #ARVO2023 conference next week and connect with leading retinal disease researchers. As a preclinical CRO, I'm looking forward to engaging in insightful discussions and advancing our collective understanding of ocular diseases. #ophthalmology #research